... Health, New York City; David Pisetsky, M.D., Ph.D., professor, medicine, Duke University School of Medicine, Durham, N.C., and member, scientific advisory board, Lupus Research Alliance; Feb. 19, 2019, Annals of the Rheumatic Diseases, onlineCopyright © 2019 All rights reserved. ...
Gut Microbes May Help Drive Lupus, Study Finds
... Health, New York City; David Pisetsky, M.D., Ph.D., professor, medicine, Duke University School of Medicine, Durham, N.C., and member, scientific advisory board, Lupus Research Alliance; Feb. 19, 2019, Annals of the Rheumatic Diseases, onlineCopyright © 2019 All rights reserved. ...
... and Paediatric Lupus Nephritis — Annals of the Rheumatic Diseases Relationship Between Prednisone, Lupus Activity and Permanent Organ Damage — The Journal of Rheumatology Managing Side Effects of Steroids — Lupus Foundation of America Infections in Newly Diagnosed Spanish Patients With Systemic Lupus Erythematosus: Data From the RELES Cohort — Lupus ...
Is 20 Milligrams of Prednisone a Low Dose?
... and Paediatric Lupus Nephritis — Annals of the Rheumatic Diseases Relationship Between Prednisone, Lupus Activity and Permanent Organ Damage — The Journal of Rheumatology Managing Side Effects of Steroids — Lupus Foundation of America Infections in Newly Diagnosed Spanish Patients With Systemic Lupus Erythematosus: Data From the RELES Cohort — Lupus ...
... Teaching Tools — New York State Department of Health Mixed Connective Tissue Disease: Disease Overview — National Organization for Rare Disorders Raynaud’s Disease — Mayo Clinic Pos1160 Clinical Characteristics and Response to Standard-of-Care in Systemic Lupus Erythematosus Patients With or Without Anti-Ribonucleoprotein (RNP) Antibodies — Annals of Rheumatic ...
RNP Antibodies and Lupus: What Do They Mean?
... Teaching Tools — New York State Department of Health Mixed Connective Tissue Disease: Disease Overview — National Organization for Rare Disorders Raynaud’s Disease — Mayo Clinic Pos1160 Clinical Characteristics and Response to Standard-of-Care in Systemic Lupus Erythematosus Patients With or Without Anti-Ribonucleoprotein (RNP) Antibodies — Annals of Rheumatic ...
... — Lupus Foundation of America The Worldwide Incidence and Prevalence of Systemic Lupus Erythematosus: A Systematic Review of Epidemiological Studies — Rheumatology Clinical and Immunological Pattern of Systemic Lupus Erythematosus in Men in a Cohort of 2355 Patients — International Journal of Rheumatic Diseases Gender Differences in the Pathogenesis ...
Lupus in Men: What You Need To Know
... — Lupus Foundation of America The Worldwide Incidence and Prevalence of Systemic Lupus Erythematosus: A Systematic Review of Epidemiological Studies — Rheumatology Clinical and Immunological Pattern of Systemic Lupus Erythematosus in Men in a Cohort of 2355 Patients — International Journal of Rheumatic Diseases Gender Differences in the Pathogenesis ...
... References Three Years Is the Minimal Effective Duration of Sustained Clinical Remission Which Prevents Impaired Kidney Function and Damage Accrual in Lupus Nephritis — Annals of the Rheumatic Diseases Lupus Nephritis — Cleveland Clinic New Treatment Guidelines for Lupus Nephritis Shift Focus to Continuous Therapy — Lupus Foundation of America ...
3 Years of Lupus Nephritis Remission May Help Prevent Long-Term Kidney Damage
... References Three Years Is the Minimal Effective Duration of Sustained Clinical Remission Which Prevents Impaired Kidney Function and Damage Accrual in Lupus Nephritis — Annals of the Rheumatic Diseases Lupus Nephritis — Cleveland Clinic New Treatment Guidelines for Lupus Nephritis Shift Focus to Continuous Therapy — Lupus Foundation of America ...
... Restart in Patients With SLE: An Open-Label, Non-Randomised 52-Week Study — Arthritis Research & Therapy B Cell Activating Factor (BAFF): Structure, Functions, Autoimmunity and Clinical Implications in Systemic Lupus Erythematosus (SLE) — Autoimmunity Reviews POS0107 Tapering Belimumab in Patients With SLE: A Single Center Experience — Annals of the Rheumatic ...
Stopping Belimumab: 4 Withdrawal Effects To Look For
... Restart in Patients With SLE: An Open-Label, Non-Randomised 52-Week Study — Arthritis Research & Therapy B Cell Activating Factor (BAFF): Structure, Functions, Autoimmunity and Clinical Implications in Systemic Lupus Erythematosus (SLE) — Autoimmunity Reviews POS0107 Tapering Belimumab in Patients With SLE: A Single Center Experience — Annals of the Rheumatic ...
... ReferencesThe Impact of Upper Limb Exercise on Function, Daily Activities and Quality of Life in Systemic Lupus Erythematosus: A Pilot Randomised Controlled Trial — Rheumatic & Musculoskeletal Diseases ...
... ReferencesMindfulness Meditation: A Primer for Rheumatologists — Rheumatic Diseases Clinics of North America ...
... If you’re thinking about taking an antidepressant, it’s important to know which lupus medications you’re already taking.Hydroxychloroquine (Plaquenil) is a medication used to treat lupus and other rheumatic diseases. This antimalarial drug can help relieve pain and inflammation and prevent flares. ...
Hydroxychloroquine and Antidepressants: What To Know for Lupus
... If you’re thinking about taking an antidepressant, it’s important to know which lupus medications you’re already taking.Hydroxychloroquine (Plaquenil) is a medication used to treat lupus and other rheumatic diseases. This antimalarial drug can help relieve pain and inflammation and prevent flares. ...
... References Ehlers-Danlos Syndrome — StatPearls Collagen — Cleveland Clinic Ehlers-Danlos Syndrome Hypermobility Type Is Associated With Rheumatic Diseases — Scientific Reports Association of Mast-Cell-Related Conditions With Hypermobile Syndromes: A Review of the Literature — Immunologic Research Ehlers-Danlos Syndrome — Mayo Clinic ...
Lupus and Ehlers-Danlos Syndrome: Is There a Connection?
... References Ehlers-Danlos Syndrome — StatPearls Collagen — Cleveland Clinic Ehlers-Danlos Syndrome Hypermobility Type Is Associated With Rheumatic Diseases — Scientific Reports Association of Mast-Cell-Related Conditions With Hypermobile Syndromes: A Review of the Literature — Immunologic Research Ehlers-Danlos Syndrome — Mayo Clinic ...
Join
Your Privacy Choices
